drugset / Trial / NCT01098305
Efficacy of Varenicline for Smokeless Tobacco Use in India
Phase 2
Completed
237 enrolled
University of Pennsylvania
All India Institute of Medical Sciences · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study, based in India, is testing the efficacy of varenicline to help smokeless tobacco users with cessation efforts.
Timeline
- Start
- 2011-04
- Primary completion
- 2012-10
- Completion
- 2013-10
Publications
- Livingstone-Banks J, Fanshawe TR, Thomas KH, Theodoulou A, Hajizadeh A, Hartman L, Lindson N. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2023 May 5;5(5):CD006103. doi: 10.1002/14651858.CD006103.pub8.
- Jhanjee S, Jain R, Jain V, Gupta T, Mittal S, Goelz P, Schnoll RA. Evaluating the Effects of Varenicline on Craving, Withdrawal, and Affect in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline for Smokeless Tobacco Dependence in India. J Psychoactive Drugs. 2015 Sep-Oct;47(4):325-30. doi: 10.1080/02791072.2015.1075092. Epub 2015 Aug 28.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Varenicline | Small molecule | 1 mg | — |